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Objective: The brachial artery is often used for coronary angiography. However, data on brachial access for aortic and
peripheral interventions are limited. This study evaluated our experience with brachial artery catheterization for
diagnostic arteriography and endovascular interventions.
Methods: Between August 2004 and August 2005, 2026 endovascular procedures were performed. Of these, 323 cases
(16%) in 289 patients required brachial artery access, forming the basis for this study. Patients who underwent multiple
interventions, but with a single access (ie, thrombolysis), were considered a single case. Demographic and clinical data
were recorded in a database and analyzed using logistic regression analyses with generalized estimating equations and the
Fisher exact test for nominal variables.
Results: The mean age of all patients was 66.4 years, with 57% men. Brachial access was used for diagnostic purposes in
27% and for interventions including angioplasty, stenting, and thrombolysis in 73%. The use of brachial access was
considered obligatory in 40%, adjunctive in 19% (ie, endovascular repair of abdominal aortic and thoracic aortic
aneurysms) and preferential to femoral access in 41%. In 91% of patients, the brachial arteries were accessed percutane-
ously, and 9% underwent surgical cutdown for access. In patients whose brachial artery was approached percutaneously,
access was achieved in all but one (99.6% technical success rate). Hemostasis after catheterization was achieved by manual
compression in 89%. Operative mortality rate was 6.2% and not related to brachial artery access. Brachial access
site–related complications occurred in 21 patients (6.5%). Thirteen of these 21 patients (62%) required a surgical
correction, mostly for brachial artery thrombosis or pseudoaneurysm. Patients with complications were more commonly
women (odds ratio [OR], 4.7; 95% confidence interval [CI], 1.68-13.26; P .003) and had a long interventional sheath
(OR, 6.7; 95% CI, 1.53-29.07; P  .012). The risk of a brachial artery complication was not associated with
thrombolysis, procedure type, vascular territory treated, or the use of heparin. No upper extremity limb or finger loss
occurred.
Conclusions: Brachial artery access is necessary for complex endovascular procedures and can be achieved in most patients
safely. Postprocedural vigilance is warranted because most patients with complications will require operative correction.
(J Vasc Surg 2009;49:378-85.)Endovascular diagnostic and therapeutic procedures
are generally performed through the femoral artery. Some
of the reasons for this generalized approach are its location,
easy approach for puncture and hemostasis, and low rate of
complications. Femoral puncture also allows access to vir-
tually all of the arterial territories and affords favorable
ergonomics for the operator in most instances. In some
situations, however, femoral access can be difficult or even
contraindicated, such as in the absence of palpable femoral
pulses, severe common femoral occlusive disease, recent
femoral intervention or surgery, femoral aneurysms/
pseudoaneurysms, and in some cases, the presence of pros-
thetic material. Access through other vessels, including the
brachial, radial, and ulnar, has been used when femoral
access is unavailable. Considerable experience has been
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378achieved with these approaches for endovascular interven-
tions of the coronary arteries, with excellent technical re-
sults and a low incidence of complications.1-3
The use of brachial artery access for noncoronary inter-
ventions, however, has received less attention. Despite its
utility as an adjunctive4 and sometimes obligatory technique,
some endovascular surgeons are reluctant to broaden its use
for fear of an increased rate of complications. Several series
have documented complication rates as high as 11%.5-7
The purpose of this study was to evaluate our experi-
ence with brachial artery catheterization in diagnostic and
therapeutic endovascular procedures. In particular, our
goals were to assess short-term technical success, safety, and
the relationship between perioperative factors and compli-
cations related to brachial artery access.
PATIENT AND METHODS
We reviewed our experience with endovascular proce-
dures that required brachial access for diagnostic or thera-
peutic interventions at Cleveland Clinic from August 2004
to August 2005. During these 13 months, 2026 endovas-
cular procedures were performed in endovascular suites
with dedicated imaging equipment. This study comprised
323 cases (16%) in 289 patients who required brachial
artery access. Patients who underwent multiple interven-
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sidered a single procedure. All cases of thrombolysis lasted
24 hours (mean, 30 hours).
All demographic, clinical, and perioperative data were
obtained through review of hospital and physician comput-
erized records. Demographic data points were collected
that could potentially affect the peripheral vasculature in
terms of size of the artery, degree of calcification, accelerated
atherosclerosis, or perfusion. The data points studied in-
cluded age, sex, and comorbidities of hypertension, hyper-
lipidemia, diabetes mellitus, coronary artery disease, history
of congestive heart failure, presence of renal disease,
chronic obstructive pulmonary disease, and smoking his-
tory. The numbers of observations were slightly variable
due to missing data in the patient record. Thus, not all
demographic and perioperative data points totaled to 289
patients or 323 cases. The operative reports and selected
radiologic imaging were reviewed. Finally, time of last
follow-up was recorded as well as the presence or absence of
postoperative complications. Average length of follow-up
was 18.6 (SD 11) months.
Operative technique. Diagnostic angiograms and en-
dovascular procedures were performed by the faculty of the
Cleveland Clinic Department of Vascular Surgery in dedi-
cated endovascular suites with fixed imaging. The left bra-
chial artery was accessed in 85% because it provided a more
direct route to the descending thoracic aorta, abdominal
aorta, and lower extremities and avoided catheter traversal
of the aortic arch. Most arteries were accessed percutane-
ously using a micropuncture kit (Cook Inc, Bloomington,
Ind). It is our practice to puncture approximately 1 cm
above the antecubital crease. A strong pulse can usually be
felt at this location, and it allows for the brachial artery to be
compressed against the distal humerus for hemostasis at the
end of the procedure. Ultrasound (US)-guided access was
not used routinely, and was reserved for 27 instances where
cannulation of the artery by palpation was unsuccessful.
Primary surgical cutdown was performed selectively in
29. This decision was made preoperatively according to the
surgeon’s preference. Indications for cutdown included a
small or difficult to palpate brachial artery, or the placement
of 7F sheath, or both. Procedures that involved brachial
artery access included diagnostic angiograms, abdominal or
thoracic aortic stent grafting, percutaneous angioplasty/
stenting, and thrombolysis.
Indications for brachial artery access were differentiated
according to whether the approach was by surgeon’s pref-
erence, used obligatorily, or as an adjunct. Obligatory use
of the brachial artery was defined as occurring in a situation
where the femoral artery was unavailable, such as nonpal-
pable pulse, recent femoral intervention or surgery, pres-
ence of severe common femoral occlusive disease, femoral
aneurysms, and in some cases, prosthetic material. The
presence of prosthetic material at the femoral artery punc-
ture site refers to Dacron or polyethylene bypass graft
material. In some patients with an iliofemoral, femoro-
femoral, or aortobifemoral bypass, femoral artery puncture
was considered contraindicated for fear of infecting thegraft or inability to achieve hemostasis after puncture ren-
dering a higher risk of pseudoaneurysm development.
Adjunctive use of the brachial artery was defined as a
case in which the femoral artery had been accessed but an
additional access through the brachial artery was deemed
necessary for successful completion of the procedure. All
vascular territories were treated, including brachiocephalic
vessels, the aorta, the visceral vessels, and the lower extrem-
ity.
Most patients received heparin. Activated clotting time
(ACT) levels were not monitored routinely except for
carotid stenting and endovascular repair of abdominal or
thoracic aortic aneurysms, our target ACT is 300 sec-
onds. The level is checked every 30 minutes.
A long interventional sheath (10 cm) was used in 56%
of the procedures. The lengths of the long sheaths used
during that period of time ranged from 55 to 90 cm. If the
size of the long sheath used was not indicated in the
operative reports, we chose 10 cm as our cutoff between a
short and long sheath because 10 cm is the size of the short
sheath that we routinely use for initial access. Sheath sizes
used ranged from 4F to 9F. Manual pressure was used in
virtually all cases of percutaneous access. The decision to
remove the sheaths was surgeon dependent, and was often
a judgement based on the amount of heparin given, the
time interval between when the heparin was given and the
conclusion of the case, and whether the heparin was re-
versed with protamine.
A surgical closure was used in 29 procedures in which
the artery was accessed with a surgical cutdown. In 17 of
these, sheaths5F were used. In seven instances a surgical
cutdown was used to close an artery that had been accessed
percutaneously.
Data analysis and statistical methods. The primary
goal was to assess the relationship between perioperative
factors with brachial artery complications. To assess this
relationship, a logistic regression model with generalized
estimating equations using an exchangeable correlation
structure was fit, allowing for the control of the correlation
between observations from the same patient. When these
models would not converge, due to levels with all compli-
cations or without any complications, a Fisher exact test
was performed. The Fisher exact test did not adjust for the
correlation between surgeries on the same patient. Analyses
were performed using SAS 9.1 software (SAS Institute,
Cary, NC), and a significance level of 0.05 was assumed for
all tests. Multivariable analyses was explored, but aban-
doned due to the small number of complications.
RESULTS
The mean age of all patients undergoing brachial artery
access for endovascular procedures was 66.4 years (range,
23 to 90 years), and 57% were men. Most patients were
hypertensive (82%) and had a history of smoking (76%).
Patients were being treated for hyperlipidemia (67%), cor-
onary artery disease (56%), diabetes mellitus (24%), and
chronic obstructive pulmonary disease (24%). Patients were
receiving the following medications preoperatively: aspirin
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ers Squibb, Princeton, NJ), a -blocker (57%), and a statin
(46%). The remainder of the demographic background of
the patients in this study is given in Table I.
In reviewing the indications for accessing the brachial
artery, we found that brachial artery access was used as a
matter of preference in 131 patients (41%), was considered
obligatory in another 130 (40%), and was used as an
adjunctive access to facilitate cases (ie, mostly endovascular
abdominal aortic and thoracic aortic aneurysm repair) in 62
(19%). The procedures were elective in 77%. Brachial access
was used for diagnostic purposes in 27% and for therapeutic
intervention, including angioplasty, stenting, and throm-
bolysis in 73%. The distribution of the types of procedures
is given in Fig 1, and the vascular territories treated are
given in Fig 2.
Percutaneous access was used for brachial artery access
in 91% of the procedures and primary cutdown in 9%. One
Table I. Demographic features for 289 study patients
Variables Percentage or mean
Age, y 66.4 (range, 23 to 90 years)
Male gender 57
Hypertension 82
Hyperlipidemia 67
Coronary artery disease 56
Smoking history
Active 29
Former 47
Congestive heart failure 18
Diabetes mellitus 24
Renal insufficiency 29
COPD 24
Preoperative medications
Clopidogrel 23
Aspirin 51
Coumadina 15
-Blocker 57
Statin 46
COPD, Chronic obstructive pulmonary disease.
aBristol-Myers Squibb, Princeton, NJ.
Fig 1. The distribution of indications for brachial access. EVAR,
Endovascular aneurysm repair; PTA, percutaneous transluminal
angioplasty/stenting.brachial artery was unable to be accessed percutaneously,yielding a technical success rate of 99.6%. In that patient the
brachial artery was accessed by needle puncture, but cath-
eter introduction was unsuccessful. An angiogram through
the 4F sheath revealed a small brachial artery unsuitable for
the intervention, and the procedure was then achieved
through an axillary access.
The left arm was used in 85% of the cases, the right arm
in 13.8%, and both arms in 1.2%. The right brachial artery
was catheterized in nearly all patients to treat thoracoab-
dominal pathology, such as with second-stage elephant
trunk procedures, thoracic endovascular aneurysm repair
requiring coverage of the left subclavian artery, dissection,
or rupture. In some patients the right brachial artery was
catheterized for ipsilateral ischemic disease of the upper
extremity or for lower extremity disease if the left brachial
artery had a weak pulse or an arteriovenous fistula or graft
was in place.We did not observe any difference in frequency
of complications between the arm used (left [7.0%] vs right
[4.6%]; P .81). In addition, there were no complications
in the four patients who underwent bilateral puncture.
Ultrasound guidance was used in 27 procedures (8%)
when access was difficult because of the patient’s body
habitus, a small artery, or a weak pulse. Heparin and pro-
tamine were used selectively. Heparin was given in 68% of
cases and protamine was used to reverse the anticoagulation
in 30%.
Sheath diameter varied according to the nature of the
procedure. A 4F or 5F sheath was used in 61% of cases, a 6F
or 7F sheath in 31%, and 8% required an8F sheath. Short
sheaths (10 cm) were used in 44%, and long sheaths,
which varied in length from 55 to 90 cm, were required for
the endovascular procedure in 56%. No significant differ-
ence in the complication rate was noted among the various
sheath sizes used.
Manual pressure was used to achieve hemostasis upon
sheath removal in 89% of procedures. In the remaining, the
artery was closed surgically. Conversion to surgical closure
was needed in 2.3% when the artery was initially cannulated
percutaneously. The decision to surgically repair an artery
Fig 2. The distribution of vascular territories treated using bra-
chial artery access.that had been percutaneously accessed was largely accord-
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included how small the artery was felt to be and the size of
the interventional sheath. There were two notable cases. In
one patient, the tip of the intravascular ultrasound catheter
sheared and remained in the brachial artery. A cutdown was
performed and the foreign body was successfully removed.
In another patient, a 5F sheath was placed for a mesenteric
angiogram. Sheath placement was successful but difficult.
Upon surgical cutdown, the artery was noted to have
transected and required repair with an interposition vein
graft.
There was no significant difference in the incidence of
adverse events and the technique of hemostasis of the
puncture site between manual compression and surgical
closure (6.6 vs 5.6%; P .64). Of the two patients who had
complications after surgical closure, both accesses were
achieved percutaneously but required open closure of the
arterial wall. The first corresponds to our one technical
failure, a woman with acute mesenteric ischemia where the
brachial artery was cannulated by puncture but efforts were
unsuccessful for catheter introduction due to a severely
diseased artery. The procedure was completed through an
axillary approach, and the brachial artery was closed surgi-
cally. Re-exploration was required for continuous oozing
postoperatively, with evidence of bleeding from a small
vein.
The second occurred in a woman with chronic mesen-
teric ischemia who underwent superior mesenteric artery
angioplasty for in-stent restenosis. The access was gained
percutaneously but required conversion after the endovas-
cular procedure was completed owing to a brachial lacera-
tion that required placement of an interposition vein graft.
The postoperative complication identified was a small an-
tecubital hematoma managed conservatively.
We did not observe any complications in those patients
who underwent a primary cutdown for artery exposure and
cannulation and subsequent surgical closure.
Overall technical success for the intended endovascular
procedure, whether diagnostic or therapeutic, was achieved
in 94.4%. The operative mortality rate was 6.2% and not
related to brachial artery access. Complications related to
the brachial access occurred in 21 patients (6.5%). Pseudo-
aneurysmwas themost common complication, followed by
brachial artery thrombosis, the latter only occurring in
women (Table II). Overall, 13 of these patients (62%)
required a surgical procedure to address the complication.
There was no median nerve dysfunction or upper extremity
Table II. Complications related to brachial artery access
Complication
Patients (n  21),
No. (%)
Need for surgical
repair, No.
Pseudoaneurysm 11 (52) 5
Brachial artery thrombosis 7 (33) 7
Hematoma 3 (14) 1limb or finger loss in this experience.The only demographic feature that was associated with
a higher rate of complications was female gender (odds
ratio [OR], 4.7, P .003). No other preoperative features
were associated with increased complication risk, including
diabetes mellitus (P  .28), renal disease (P  .65), and
increasing body mass index (P  .28). The relationship
between complication risk and certain medications, such as
anticoagulants and antiplatelets, was also studied (Table III).
Interestingly, the use of aspirin was associated with lower
rate of brachial artery complications (OR, 0.3; P  .015).
Patients who were prescribed Coumadin preoperatively
appeared to have a trend for increased complications (OR,
2.4; P  .086).
The only intraoperative variable that was associated
with a higher rate of complications was use of a long (10
cm) interventional sheath (OR, 6.7; P  .012). Larger
sheath sizes did not translate into a higher complication risk
(P  .23), although there was a trend toward higher
complication risk with 6F/7F sheaths (OR, 2.3; P .094).
The risk of a brachial artery complication was not associated
with procedure type, including thrombolysis (P  .23) or
the vascular territory that was treated (P  .47). Also, the
use of heparin or protamine was not associated with an
increased complication risk (Table IV).
DISCUSSION
Brachial artery access is a critical component of complex
endovascular procedures. The routine use of femoral access
is widespread secondary to its technical ease, wide applica-
bility, and relative patient comfort. In our experience of
2000 endovascular cases in a 1-year period, femoral can-
nulation was also routine; however, brachial access was
used in 16% of procedures. This may be due to the emer-
gence of newer and more complex techniques that require
multiple access points to achieve procedural success.
Brachial access is a straightforward procedure with a
high success rate for percutaneous cannulation. Some tech-
nical points are worthy of mention. Our practice is to
routinely use a micropuncture system with puncture just
proximal to the antecubital fossa. This is visualized fluoro-
scopically over the olecranon process. High bifurcation of
the brachial artery or high origin of the radial artery from
the brachial artery is the most frequent arterial variation
of the upper extremity.8We are not aware of any instance in
our series in which the radial or ulnar vessel was punctured;
inadvertent puncture may have occurred, but to our knowl-
edge this was not associated with any complications. Hep-
arinization is instituted after placement of a sheath.
Braided, flexible long sheaths are used for interventions,
and manual pressure is used for hemostasis.
Technical success for percutaneous brachial access in
our series was 99.6%, with only one failure. Other groups
have reported similar rates. Basche et al9,10 described a
technical success rate of 99.5% for diagnostic and 94% for
therapeutic procedures, respectively. Similar findings in
diagnostic procedures were described by Chatziioannou
et al,11 who reported a 99.52% success rate in catheterizing
one of the brachial arteries for lower extremity arteriography.
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Variable Group No. Complications, No (%) OR (95% CI) P
Female No 184 5 (2.7) 1.00 (1.00-1.00) .003
Yes 139 16 (11.5) 4.72 (1.68-13.26)
Hyperlipidemia No 85 6 (7.1) 1.00 (1.00-1.00) .93
Yes 220 15 (6.8) 0.96 (0.36-2.58)
CAD Low 139 10 (7.2) 1.00 (1.00-1.00) .62
Intermediate 148 8 (5.4) 0.74 (0.28-1.94)
High 30 3 (10) 1.45 (0.37-5.75)
CHF No 256 16 (6.3) 1.00 (1.00-1.00) .83
Yes 57 4 (7) 1.13 (0.36-3.55)
CVD No 240 14 (5.8) 1.00 (1.00-1.00) .43
Yes 72 6 (8.3) 1.50 (0.55-4.11)
DM No 241 18 (7.5) 1.00 (1.00-1.00) .28
Yes 77 3 (3.9) 0.50 (0.14-1.76)
Hypertension No 52 3 (5.8) 1.00 (1.00-1.00) .81
Yes 266 18 (6.8) 1.17 (0.33-4.19)
Tobacco None 45 2 (4.4) 1.00 (1.00-1.00) .70
Former 151 10 (6.6) 1.51 (0.32-7.20)
Active 97 8 (8.3) 1.94 (0.39-9.63)
COPD No 231 14 (6.1) 1.00 (1.00-1.00) .33
Yes 75 7 (9.3) 1.60 (0.62-4.16)
Aspirin No 134 15 (11.2) 1.00 (1.00-1.00) .015
Yes 166 6 (3.6) 0.30 (0.11-0.79)
Clopidogrel No 227 17 (7.5) 1.00 (1.00-1.00) .52
Yes 76 4 (5.3) 0.69 (0.22-2.13)
Coumadinb No 256 15 (5.9) 1.00 (1.00-1.00) .086
Yes 46 6 (13) 2.39 (0.88-6.44)
-Blocker No 119 8 (6.7) 1.00 (1.00-1.00) .91
Yes 185 13 (7) 1.05 (0.42-2.63)
Statin No 114 8 (7) 1.00 (1.00-1.00) .60
Yes 148 8 (5.4) 0.76 (0.28-2.09)
CAD, Coronary artery disease; CHF, congestive heart failure; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular
disease; DM, diabetes mellitus; OR, odds ratio.
aThe total number of observations varies slightly due to missing data in the patient record.
bBristol-Myers Squibb, Princeton, NJ.Table IV. Relationship between intraoperative variables and rate of complications
Variable Group No. Complications, No. (%) OR (95% CI) P
Indication Elective 247 19 (7.7) 1.00 (1.00-1.00) .14
Urgent 76 2 (2.6) 0.33 (0.08-1.43)
Vascular Carotid 11 1 (9.1) 1.00 (1.00-1.00) .47
Territory Aorta 126 6 (4.8) 0.50 (0.06-4.51)
Viscerals 92 9 (9.8) 1.09 (0.13-9.40)
LExt 94 5 (5.3) 0.57 (0.06-5.24)
US guided No 296 17 (5.7) 1.00 (1.00-1.00) .077
Yes 27 4 (14.8) 2.86 (0.89-9.15)
Heparin use No 104 7 (6.7) 1.00 (1.00-1.00) .92
Yes 219 14 (6.4) 0.95 (0.37-2.43)
Protamine No 226 18 (8.0) 1.00 (1.00-1.00) .12
Yes 97 3 (3.1) 0.37 (0.11-1.29)
Intervention No 109 4 (4.6) 1.00 (1.00-1.00) .32
via BA Yes 214 16 (7.5) 1.68 (0.60-4.69)
Sheath diameter 4F-5F 186 8 (4.3) 1.00 (1.00-1.00) .23
6F-7F 95 9 (9.5) 2.33 (0.87-6.23)
8F 23 1 (4.4) 1.03 (0.12-8.48)
Sheath length Short 133 2 (1.5) 1.00 (1.00-1.00) .012
Long 172 16 (9.3) 6.67 (1.53-29.07)
Hemostasis Manual 286 19 (6.6) 1.00 (1.00-1.00) .89
Surgical 36 2 (5.6) 1.35 (0.38-4.85)BA, Brachial artery; CI, confidence interval; LExt, lower extremity; OR, odds ratio; US, ultrasound.
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with 2250 brachial artery punctures. These procedures,
however, used a 4F pigtail catheter without placement of a
sheath.11
Complications occurred in 21 of 323 procedures
(6.5%). We sought to identify factors associated with a
complication and found no evidence that any of the preop-
erative demographic variables, other than female gender,
significantly affected the incidence of brachial access related
complications. Women had an 11.5% complication rate
compared with 2.7% in men (P  .003). Complications
were also managed differently in women compared with
men: an open surgical procedure was required in 75% of
women but in only 20% of men to resolve the complication.
It is important to emphasize that the seven complications
with brachial artery thrombosis occurred in women, and all
of them required surgical correction. In general, this cor-
relates with data in the femoral artery access literature.
Applegate et al12 reported an incidence of vascular compli-
cations of 1.0% in men vs 2.0% in women (P  .05) after
coronary interventions through a femoral approach.12 The
largest report of vascular complications after coronary in-
terventions, the ACC-NCDR, reported a twofold increase
in the risk of any vascular complication for women com-
pared with men.13 This may simply be due to smaller
brachial artery diameter and endothelial damage from
sheaths, catheters and guidewires.
An interesting finding was the positive effect of aspirin
use on the incidence of complications (P  .015). Perhaps
an antiplatelet effect decreased the likelihood of brachial
thrombosis without an increased risk of significant bleed-
ing. However, patients with history of Coumadin use
trended toward increased complications (P  .086).
There is a general reluctance to puncture the right
brachial artery due to the need to navigate through the
innominate artery and arch. This may put multiple cerebral
arteries (carotid and vertebral) at risk for embolization.
However, we did not identify any patient with a cerebro-
vascular accident complication, and found no difference in
the incidence of complications when we compared the two
arms for brachial access. Several groups with experience
using the right brachial system have suggested that it is not
associated with an increased risk of cerebrovascular compli-
cations.11,14,15
The risk for vascular complications has been reported to
be higher in those patients undergoing therapeutic inter-
ventions compared with diagnostic procedures in coro-
nary12 and peripheral vascular cases.16 Similarly in our
experience, the use of long sheaths (10 cm long) was
associated with a significant risk of puncture site complica-
tions (9.3 vs 1.5%; P  .012). The introduction and ma-
nipulation of these sheaths to reach distant targets may add
additional strain on the relatively mobile brachial artery.We
were surprised that we did not find a significant relationship
between the incidence of complications and the sheath size.
There was a trend toward increased complications in the 6F
to 7F range, although not statistically significant. That
trend reversed itself with the use of sheaths 8F; however,with those cases that required the use of a sheath 8, the
sheath was introduced by primary cutdown in 11 (48%).
Nonetheless, no complications occurred in the percutane-
ously accessed arteries with an 8F sheath in place.
The 3.4% rate of complications in diagnostic proce-
dures in our series is within the 0.44% to 11% range
reported by other groups.6,11,17,18,19 In our series, surgical
intervention for local brachial artery complications in both
diagnostic and therapeutic procedures was necessary in 4%
of the procedures. One patient of 87 (1.1%) undergoing
diagnostic angiography needed a surgical procedure for a
brachial-related complication.
Ultrasound-guided cannulation has been used for sev-
eral years as an adjunct for arterial and venous cannulation.
In particular, with regard to internal jugular vein access, the
success rate is improved, access time is decreased, and the
complication rate is reduced significantly.20 We used US
imaging selectively, mostly in difficult cases. We observed
four complications in the 27 cases of US-guided cannula-
tion (14.8%) vs 17 events in 296 palpation-guided (5.7%)
procedures. This finding should be taken with caution,
however, considering that we do not use US imaging
routinely in all patients, reserving its use only for those
arteries difficult to cannulate by palpation. We advocate the
use of US-guided access in complicated procedures, but
our data would indicate that this may serve as a warning that
an increased risk of brachial artery complication may occur.
Some groups have described the successful use of clo-
sure devices for brachial punctures.21,22 Our experience
with the closure devices in the brachial location is limited,
and none were used in this particular series. The currently
available devices have been designed for femoral puncture
closure exclusively.Most require an adequate subcutaneous
tissue thickness to be deployed safely, as well as an arterial
diameter that is more generous than in most brachial
arteries. Brachial specific closure devices may be warranted
with increased use of this access site.
Pseudoaneurysm formation complicates 0.6% to 6% of
femoral arterial catheterizations.23-25 Risk factors for post-
catheterization femoral pseudoaneurysm have been de-
scribed and include use of anticoagulation, large sheath
size, hypertension, obesity, faulty puncture technique,
inadequate manual compression after catheter removal,
arterial calcification, simultaneous arterial and venous
cannulation, female gender, and hemodialysis.25-27 Also,
interventions requiring large sheath size and use of peripro-
cedural anticoagulation may increase pseudoaneurysm for-
mation because they are less common after diagnostic
angiography.25-27 In this series, brachial pseudoaneurysm
(n  11) was the most frequently observed complication
after brachial artery access. The incidence of brachial
pseudoaneurysms was 5.7% in women and 2.2% in men;
this difference was not significant (P  .17). We identified
two pseudoaneurysms (2.3%) after 87 diagnostic proce-
dures. Although only five required surgical repair, four still
required an intervention with US-guided thrombin injec-
tion. One patient was managed with US-guided compres-
sion, and the last one resolved spontaneously with observa-
JOURNAL OF VASCULAR SURGERY
February 2009384 Alvarez-Tostado et altion. No median nerve injuries occurred in this series. The
incidence of this complication after right brachial artery
puncture for cardiac catheterization was 0.2% to 1.4% in the
cardiology literature.28 The mechanism of injury was direct
nerve compression from hematoma, direct nerve trauma,
and ischemia from brachial artery occlusion. We credit the
absence of median nerve injury in our series to the fact that
our complications were noted early and treated accordingly
in the postoperative period.
There are limitations to this study. This is a retrospec-
tive, nonrandomized study in a referral center where many
of the patients are from out-of-state locations. Thus, con-
sistent follow-up is difficult and complications may have
been missed. Nevertheless, most patients did follow-up
with us with a mean follow-up of 18 months. Choice of
percutaneous vs cutdown brachial access (n  29) and
other technical details were left to the surgeon treating the
patient, leading to inherent biases. Clinical testing was not
standardized and left to the discretion of the treating
physician. Thus, all patients did not have a brachial artery
duplex or other noninvasive imaging; this was performed
based on clinical suspicion. Lastly, conclusions regarding
the use of antiplatelet and anticoagulant agents should be
made with caution. Because this was a retrospective review,
we did not have consistent documentation on how long
oral anticoagulants and antiplatelet agents were stopped
before the procedure. In addition, some patients who were
known to be taking Coumadin did not have an interna-
tional normalized ratio available on the day of procedure to
know if they had been fully reversed.
In conclusion, brachial artery access is necessary for
complex endovascular procedures and can be achieved in
most patients safely. This technique expands our capability
to perform complex procedures by allowing us to reach
arterial targets in all territories. Female gender was associ-
ated with an increased risk of complications, as was use of a
long sheath. The risk of a brachial complication is low, but
postprocedural vigilance is warranted in all cases of brachial
artery access since amajority of patients with a complication
will require operative correction.
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Dr Nicholas Morrissey (New York, NY). I think it is a very
nice study; it capitalizes on the large volume that you guys see. And
seeing this number of brachial access, I think it is pretty capable of
making some strong conclusions. What I was interested in is, did
you make any attempt to correlate preoperative factors with the
need for brachial access? In other words, you noticed that certainly
female gender increased the risk of complications associated with
brachial access, but did it increase the risk of need for brachial
access? In other words, you have 2000 patients that you had
overall, what was the overall gendermixture in that group? In other
words, did female gender increase the risk of poor femoral access,
which would then require brachial access?
I am also intrigued by this concept of long vs short sheaths.
Ten-cm sheaths would basically be most of the cases that you
would be doing for diagnostic procedures, whereas the longer ones
would be indicated for interventions. And it doesn’t really shake
out that way. You seem to be using a fair number of short sheaths
for interventions. And I think if you separated out a little more
closely, you would see that intervention type, or diagnostic vs
intervention, may show a difference. I know that in the paper you
talked about the pushing of the sheath required for longer sheath
as maybe a cause for complications, but I think there may be
something more to that.
And also the risk of pseudoaneurysm. You said you had a 62%
risk of requiring surgery for pseudoaneurysms as a complication.
What happened to the other ones, were they observed? Were they
injected with thrombin?
Dr Javier A. Alvarez-Tostado. First of all, we did not inves-
tigate the relationship between preoperative factors and the need
for brachial cannulation. We tried to evaluate the relationship
between weight or body mass index; however, because it was a
retrospective study, with the limitations in our medical records, we
were not able to have enough data to investigate further.
Regarding the pseudoaneurysms, we identified that 62% of the
pseudoaneurysms needed surgery. Of those cases that were not
treated surgically, a couple of patients were followed clinically, and
basically the pseudoaneurysm thrombosed spontaneously. In one
or two cases, it was treated with injection of thrombin.
And regarding the sheath lengths, there were some interven-
tions that were actually performed through a short sheath. But in
all the cases in which a longer sheath was used, it was used for an
intervention.
As we mentioned in the manuscript, the force that you use to
introduce the longer sheath compared with the shorter sheath is
bigger. In females with skinny arms, it is very evident during thecause more trauma to the artery and increases the risk of pseudo-
aneurysm.
Dr Benjamin Jackson (Philadelphia, Pa). I just wonder, will
this—and how will it—modify your approach to endovascular
interventions in women, for instance, for renal angioplasty and
stenting and mesenteric angioplasty and stenting?
Dr Alvarez-Tostado. Well, based on this study, we cannot
make any recommendations about proceeding with a cutdown
when a longer sheath is going to be used. However, it is important
in women to have a lower threshold to convert to a cutdown in case
you notice any problem at the end of the procedure. It is important
to point out that all cases complicated with thrombosis of the
brachial artery occurred in women. Probably this is related to the
size of the vessel. I believe the indication to use the brachial access
for mesenteric or renals should be individualized. The brachial
approach might help and sometimes even be obligatory for the
cannulation and treatment of mesenteric vessels. For renals, I think
it is important to pay attention to the preoperative studies, like the
computed tomography scan, focusing on the angle of the vessel
and determine if it would be a better approach to come from the
arm.
Dr Jim Watson (Seattle, Wash). Did you differentiate at all
where the brachial artery was accessed? In my experience, starting
near the antecubital fossa, where the pulse can be easily felt and
compressed, has been relatively well tolerated. I have had more
difficulty accessing the artery higher.
Dr Alvarez-Tostado. As a retrospective study, we got our
data from the operative notes, not all of them describe the location
of the puncture site with respect to the antecubital crease. How-
ever, it is our practice to puncture approximately 1 cm above the
antecubital crease, where you feel a strong pulse and a good point
for pressure for hemostasis.
Dr Vikram Kashyap. I just want to clarify that particular
issue. So our brachial access is always over the olecranon process
and we use ultrasound selectively. A micropuncture kit I think is
important. Secondly, these data are from the vascular surgery
department database representing 2000 cases. The last presenta-
tion is from our cardiology colleagues in the heart and vascular
institute, and their data is from the cath lab.
Dr Watson. Other physicians often seem to utilize higher
brachial access near the axilla and often get away with it. But I have
had to intervene on complications of high brachial access by others,
and I try to stay low near the elbow if at all possible.
Dr Kashyap. Your guys must be lucky, because I agree with
you. A high stick should be avoided.
